Last Updated on October 6, 2024 by The Health Master
Aurobindo Pharma said the US health regulator has issued one observation after inspecting a plant owned by its US-based unit.
The US Food and Drug Administration (USFDA) conducted its Pre-Approval Inspection (PAl) and GMP (Good Manufacturing Practice) inspection from August 22-26 at the Raleigh-based plant, which has been set up for manufacturing MOl (Metered Dose Inhalers) and derma products, the Hyderabad-based drug firm said in a regulatory filing.
The plant is owned by Aurolife Pharma LLC, a wholly-owned step-down subsidiary of the company, it added.
“At the end of the inspection, Aurolife has been issued a ‘Form 483’ with one observation, and the observation is procedural in nature, and there are no data integrity issues,” Aurobindo Pharma said.
The company will respond to the USFDA within the stipulated timeline, it added.
As per USFDA, Form 483 is issued to a firm’s management at the conclusion of an inspection when the investigator has observed any conditions that, in its judgment, may constitute violations of the Food, Drug, and Cosmetic (FD&C) Act and related Acts.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
USFDA issues Form 483 with 6 observations to Cipla
UFDA issues Form 483 to Cipla’s facility in MP
USFDA issues Form 483 with 6 observations to Sun Pharma
USFDA issues Form 483 for 4 observations to Zydus
USFDA completes inspection at Stride Pharma with zero observation
USFDA issues Form 483 for 6 observations to Jubilant Pharmova
Pharma company fined for dumping medical waste in open
USFDA issues Form 483 with 6 observations to Cipla
Penalty provision for Blood Banks / Centres not updating stock in time
Govt invites eligible Medical Devices Firms Category B of PLI scheme
Drug Rules 1945 amended to allow parallel submission of manufacturing & marketing approvals
USFDA gives approval for this Contraceptive
This Air is an essential element for the Tablet Coating Process
USFDA gives nod for Formoterol Fumarate inhalation solution
NPPA fixes Retail Prices of 45 drug formulations
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
